Clinical Trial Update: Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer [Phase 2, Phase 3]

View source ↗

Summary

This trial compares postoperative concurrent chemoradiation with docetaxel versus cisplatin in high-risk oral cavity squamous cell carcinoma. The Phase 2/3 stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Oral Cavity Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: COMPLETED